BioPharm Asia, Inc. to Acquire Beijing Zhihe Ruikang Hospital Management Ltd.

NEW YORK & TONGHUA, China--(BUSINESS WIRE)--BioPharm Asia, Inc. (OTCBB: BFAR)(“BFAR” or the “Company”), a producer, distributor and retailer of medical products in China, today announced that its wholly-owned subsidiary, China Northern Pharmacy Holding Group Limited, has entered into an agreement (the “Agreement”) to acquire all of the outstanding shares of Beijing Zhihe Ruikang Hospital Management Ltd. (“ZHRK”), a professional Chinese hospital management consultation group, for a consideration of RMB2,400,000 (approximately $350,000). The Company expects to complete the acquisition of ZHRK by early July, 2010.

Back to news